Response to letter regarding article, "renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R2CHADS2 index in the ROCKET AF (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) study cohorts"

ROCKET AF Steering Committee and Investigators, Jonathan P Piccini, Susanna R Stevens, Yuchiao Chang, Daniel E Singer, Yuliya Lokhnygina, Alan S Go, Manesh R Patel, Kenneth W Mahaffey, Jonathan L Halperin, Günter Breithardt, Graeme J Hankey, Werner Hacke, Richard C Becker, Christopher C Nessel, Keith A A Fox, Robert M Califf

Research output: Contribution to journalLetter

Original languageEnglish
Pages (from-to)e172-3
JournalCirculation Research
Issue number11
Publication statusPublished - 10 Sep 2013


  • Atrial Fibrillation
  • Embolism
  • Factor Xa
  • Female
  • Humans
  • Male
  • Morpholines
  • Stroke
  • Thiophenes
  • Vitamin K

Cite this